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Abstract
Background: Asthma is a chronic inflammatory lung disease that causes significant morbidity and mortality worldwide. Air
pollutants such as particulate matter (PM) and oxidants are important factors in causing exacerbations in asthmatics, and
the source and composition of pollutants greatly affects pathological implications.
Objectives: This randomized crossover study investigated responses of the respiratory system to Stockholm subway air in
asthmatics and healthy individuals. Eicosanoids and other oxylipins were quantified in the distal lung to provide a measure
of shifts in lipid mediators in association with exposure to subway air relative to ambient air.
Methods: Sixty-four oxylipins representing the cyclooxygenase (COX), lipoxygenase (LOX) and cytochrome P450 (CYP)
metabolic pathways were screened using liquid chromatography-tandem mass spectrometry (LC-MS/MS) of bronchoal-
veolar lavage (BAL)-fluid. Validations through immunocytochemistry staining of BAL-cells were performed for 15-LOX-1,
COX-1, COX-2 and peroxisome proliferator-activated receptor gamma (PPARc). Multivariate statistics were employed to
interrogate acquired oxylipin and immunocytochemistry data in combination with patient clinical information.
Results: Asthmatics and healthy individuals exhibited divergent oxylipin profiles following exposure to ambient and subway
air. Significant changes were observed in 8 metabolites of linoleic- and a-linolenic acid synthesized via the 15-LOX pathway,
and of the COX product prostaglandin E2 (PGE2). Oxylipin levels were increased in healthy individuals following exposure to
subway air, whereas asthmatics evidenced decreases or no change.
Conclusions: Several of the altered oxylipins have known or suspected bronchoprotective or anti-inflammatory effects,
suggesting a possible reduced anti-inflammatory response in asthmatics following exposure to subway air. These
observations may have ramifications for sensitive subpopulations in urban areas.
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Introduction
Asthma is a common respiratory disorder associated with
substantial morbidity, mortality and economic cost [1]. The
prevalence of asthma is growing globally, particularly in urban
areas where polluted air is a main trigger of asthmatic
exacerbations. The pathogenesis of asthma in the urban
environment can be affected by multiple air pollutants, including
particulate matter (PM), ozone, and nitric oxides (NOx) [2,3,4]. In
terms of PM, the most studied health effects to date are related to
road emissions, which have been demonstrated to play an
important role in asthma morbidity [5]. However, there are few
studies focused on the health effects of other urban environments
such as the subway system, which represents a major form of
transportation in many cities. Even though the subway environ-
ment is a significant source of PM emission [6,7,8,9], little is
known about the biological effect(s) on the respiratory system.
Given the potential for large-scale chronic exposure to subway air,
PLoS ONE | www.plosone.org 1 August 2011 | Volume 6 | Issue 8 | e23864and the cumulative risk for sensitive populations with compro-
mised respiratory systems such as asthmatics, it is appropriate to
examine the effects of this system in greater detail. Accordingly,
the aim of this study was to investigate whether subway air can
trigger acute inflammatory responses in asthmatics and healthy
individuals.
Oxylipins are lipid mediators formed from unsaturated fatty
acids via pathways involving dioxygen-dependent oxidation [10].
These compounds exert potent and often opposing effects upon
multiple physiological processes, including inflammation and
immunity [11,12,13,14,15,16]. Three main enzymatic systems
are active in oxylipin biosynthesis: cyclooxygenase (COX),
lipoxygenase (LOX) and cytochrome P450 (CYP). Multiple
oxylipins originating from arachidonic acid (also known as
eicosanoids) are involved in asthma pathology (reviewed in [17]),
including leukotrienes (LTs; e.g., cysteinyl-LTs and LTB4), lipoxins
(LXA4 and 15-epi-LXA4) and prostaglandins (PGE2 and PGD2)
[11,16]. The biological actions of oxylipins originating from the
arachidonic acid (AA) cascade have been most extensively studied
[11,14], but the same enzymatic pathways can act on multiple
unsaturated fatty acids (e.g., linoleic- [LA] and docosahexaenoic
acid [DHA]), which are potentially equally important for
understanding disease pathology.
In this randomized crossover study, oxylipin levels were
quantified in BAL-fluid from healthy individuals and mild
asthmatics following exposure to Stockholm subway air and
ambient air. Oxylipin profiles originating from multiple unsatu-
rated fatty acid substrates from the COX, LOX and CYP
biosynthetic pathways were measured in the lower respiratory
tract, thus representing the first investigation of a number of
pharmacologically interesting non-eicosanoid oxylipin mediators
in human BAL-fluid. These data will be useful for: 1) improving
our knowledge of the role of oxylipins in pro- and anti-
inflammatory etiologies of asthma 2) understanding the mecha-
nism of toxicity triggered by subway air and associated effects
upon sensitive populations and 3) determining the basal levels of
these important lipid mediators in healthy and asthmatic
populations.
Methods
Subjects, Study Design and Sampling
Detailed descriptions of study design, exposure regimen, PM
monitoring and the subjects are given elsewhere [18,19]. In
addition to the 18 healthy subjects [18], 15 mild intermittent
asthmatics were included in the study [19] and the samples from
both populations were analyzed simultaneously under the same
conditions in randomized order. Hyperresponsiveness was tested
in asthmatics and defined as $20% fall in forced expiratory
volume in one second (FEV1) at an accumulated methacholine
inhalation dose of ,894 mg. Without challenge, asthmatics had
normal lung function with FEV1 values within the same range as
healthy individuals. b2-agonist use on demand was allowed
throughout the study, but other medications including inhaled
corticosteroids were not permitted. Participants were non-smokers,
not habitual subway commuters and refrained from subway use at
least 2 months prior to study initiation. Allergy tests were
conducted on all subjects; 13 of the asthmatics and 2 of the
healthy individuals indicated the presence of specific IgE
antibodies against common inhaled allergens (PhadiatopH, Phar-
macia-Upjohn, Uppsala, Sweden). The study was performed out
of pollen season and airway infections were not allowed within 6
weeks before exposures. Gender, age and allergy test results are
given in Table 1. All patients indicated on the provided study
forms that non-steroidal anti-inflammatory drugs (NSAIDs) had
not been taken prior to study initiation (except for patient 27, who
indicated intake of an NSAID prior to one study event. No
significant differences were observed in this individual relative to
the other study participants).
Subway exposures were conducted during rush hour (4–6pm) at
a central subway station and PM levels were monitored as
previously described [18]. The exposure site consisted of a small
room located a few meters below the platform level equipped with
large double doors at both ends of the space used for the exposure
(approximately 4 m apart), creating a space fully vented with the
subway platform air. Mouth breathing was induced using an
Table 1. Diagnosis and allergy response for study cohort.
Diagnosis Subject Gender Age Allergy response
a
Asthmatic 1 F 52 0
4 F 40 0
7 F 31 4
12 F 27 1
20 M 25 4
21 M 25 5
23 M 23 4
24 M 22 5
25 F 21 5
26 F 21 6
27 F 20 5
28 F 20 5
32 F 19 5
33 F 18 3
34 M 18 2
Healthy 2 M 46 0
3 M 42 0
5 F 36 0
6 F 31 0
8 F 29 0
9 F 28 0
10 F 27 0
11 M 27 0
13 M 26 0
14 M 26 2
16 M 25 0
17 F 24 0
18 M 24 0
19 M 24 0
22 M 22 0
29 M 18 0
30 M 18 1
31 M 18 0
aAllergy response test values are rated from 0–6 (negative; 0: ,0.35 kU/L,
positive; 1: 0.35–0.69, 2: 0.7–3.4, 3: 3.5–17.4, 4: 17.5–49, 5: 50–99, 6: .99 kU/L;
PhadiatopH, Pharmacia-Upjohn, Uppsala, Sweden). Allergy was tested against
Timothy, Acari, Horse, Cat, Mugwort, Birch, Dog, Olive, Lichwort, Fish,
Cladosporium. Maximum response level for each individual is indicated in the
table.
doi:10.1371/journal.pone.0023864.t001
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normalize breathing rates to 20 L/min/m
2 body surface for both
test groups at the subway station (‘‘Odenplan’’) and in the ambient
air environment.
The sampling time point 14 h following exposure was selected
to enable comparison with a previous exposure study performed in
a Stockholm road tunnel [20], and signifies the repair phase where
the initial inflammatory mobilization in response to acute exposure
normally is attenuated by anti-inflammatory mediators to return
the system to base-line levels. Lung function was determined
through spirometry prior to bronchoscopies. Five 50 ml aliquots of
phosphate buffered saline (PBS; 37uC) were instilled in the middle
lobe, gently aspirated and collected in a siliconized plastic bottle
kept on ice. Recovered BAL-fluids were centrifuged at 4006g for
Table 2. Oxylipin concentrations and immunostaining data from 1) Healthy controls 2) Healthy individuals following subway air
exposure 3) Asthmatic controls and 4) Asthmatics following subway air exposure.
Healthy (H) Asthmatics (A) p-values
b
Control (C) Subway (S) Control (C) Subway (S) Control Subway Healthy Asthmatics
PUFA Oxylipin
a (pM) Average CV(%)
c Average CV(%) Average CV(%) Average CV(%) H vs A H vs A C vs S C vs S
AA
d 5-HETE 199 52 170 44 306 107 240 84 0.2 0.2 0.3 0.4
12-HETE 64 95 78 109 128 57 129 153 0.01 0.4 0.6 1.0
15-HETE 672 129 666 83 1363 77 1089 99 0.04 0.2 1.0 0.3
15-KETE 142 108 126 57 227 67 185 69 0.1 0.1 0.6 0.1
LTB4 8 49 7 47 12 101 11 80 0.2 0.1 0.6 0.7
6-trans-LTB4 47 55 39 56 44 92 38 86 0.8 0.9 0.2 0.5
TXB2 64 43 60 42 66 54 63 67 0.9 0.8 0.5 0.7
PGD2 15 96 15 68 32 108 39 148 0.1 0.1 0.9 0.6
PGE2 10 48 13 87 15 50 11 89 0.04 0.7 0.4 0.1
5(6)-EET 8 70 7 48 8 71 5 34 0.8 0.1 0.5 0.2
8(9)-EET 7 72 4 58 7 46 6 59 0.7 0.1 0.04 0.3
LA
e 9-HODE 202 103 423 138 188 49 128 44 0.8 0.05 0.04 0.02
9-KODE 182 100 309 143 66 89 48 50 0.02 0.02 0.1 0.3
13-HODE 1016 97 1458 111 1646 62 1151 85 0.1 0.5 0.2 0.1
13-KODE 361 82 580 107 234 55 179 54 0.1 0.01 0.1 0.1
EKODE 495 89 705 113 189 50 155 45 0.01 0.01 0.1 0.3
9,10,13-TriHOME 262 58 312 81 193 66 116 47 0.2 0.005 0.4 0.1
9,12,13-TriHOME 446 61 543 93 446 59 267 55 1.0 0.04 0.4 0.04
9,10-DiHOME 408 38 448 44 310 51 267 77 0.1 0.01 0.3 0.3
9(10)-EpOME 1877 28 1829 31 2012 48 2083 56 0.6 0.4 0.6 0.9
12,13-DiHOME 476 41 517 50 373 53 322 75 0.1 0.03 0.3 0.3
12(13)-EpOME 1938 27 1876 33 1976 44 2058 53 0.9 0.6 0.6 0.8
a-LA
f 9-HOTE 9 129 20 161 11 48 9 55 0.5 0.2 0.1 0.1
13-HOTE 52 100 72 116 91 62 71 100 0.04 1.0 0.2 0.3
EPA
g 12-HEPE 9 101 13 67 16 99 11 108 0.1 0.6 0.1 0.4
15-HEPE 64 132 68 74 125 89 93 84 0.1 0.3 0.9 0.2
DGLA
h 15-HETrE 63 142 81 174 149 92 118 113 0.03 0.4 0.7 0.3
DHA
i 17-HDoHE 278 137 301 95 461 72 379 93 0.2 0.5 0.9 0.4
ICC
j 15-LOX-1 0.79 97 0.69 126 0.80 103 0.67 80 0.78 0.41 0.54 0.71
COX-1 1.64 47 1.38 59 1.05 69 1.19 37 0.03 0.82 0.31 0.32
COX-2 1.92 40 1.96 37 1.79 47 1.70 51 0.65 0.23 0.96 0.46
PPARc 0.55 43 0.73 89 0.60 54 0.55 63 0.93 0.29 0.80 0.41
aOxylipin levels were normalized to the BAL-volume recoveries as described in Table S2 and Table S4,
bp-values are based on unpaired for A vs H and paired Student’s T-test for C vs S, respectively. Values of p,0.05 are italicized,







jImmunocytochemistry, RFU values normalized to DAPI intensities.
doi:10.1371/journal.pone.0023864.t002
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pellet was resuspended in RPMI-1640 medium (Sigma-Aldrich,
Irvin, UK) and the viability was determined by trypan blue
exclusion. The study was approved by the Regional Ethical
Review Board Stockholm with the case numbers 2006/643-31/4
(healthy individuals) and 2007/748-31/3 (asthmatics). All patients
provided written informed consent.
Oxylipin profiling
The oxylipin analysis methods have previously been published
[21,22] and are only briefly described here. Analytical standards
and deuterated surrogates (Table S1) were obtained from either
Cayman Chemical (Ann Arbor, MI, USA), Larodan Fine
Chemicals AB (Malmo ¨, Sweden), Biomol International (Plymouth
Meeting, PA, USA) or synthesized in-house [21]. Oxylipins were
extracted from 4 ml of BAL-fluid using Waters Oasis-HBL
cartridges (Milford, MA, USA) preconditioned with wash solution
(H2O:MeOH; 95:5, in 0.1% acetic acid). BAL-fluid aliquots,
200 ml wash solution, 10 ml of surrogate standards (400 nM/
standard), 10 ml anti-oxidant and enzyme inhibitor solution
(0.2 mg/ml of butylhydroxytoluene, ethylenediaminetetraacetic
acid, thiamine pyrophosphate and iodomethacine) were applied
on cartridge, rinsed with wash solution, eluted with 0.5 ml
methanol followed by 1.5 ml ethylacetate and collected into
polypropylene tubes containing 6 ml 30% glycerol in methanol.
Solvent was stripped and the sample was re-suspended in 50 ml
methanol containing the technical standard 1-cyclohexyl-dodeca-
noic acid urea (CUDA; 800 nM). Samples were then centrifuged
and the supernatants stored at 220uC until analysis.
Oxylipin profiling was performed using 10 ml sample injections
on an Agilent 1200SL separation module (Palo Alto, CA, USA) via
a 2.06150 mm Pursuit C18 column kept at 40uC( 5mm particle
size; Varian, Lake Forest, CA, USA) coupled to an ABI
QTRAPH4000 hybrid triple quadrupole/linear ion trap mass
spectrometer (Foster City, CA, USA). The samples were kept at
4uC prior to injection. Oxylipins detected above the limit of
quantification (LOQ) were quantified, recalculated back to the
original BAL-fluid concentrations and normalized to BAL-
recovery (V[Recovered volume]/V[Instilled volume]). Normalization to
BAL-recovery did not affect the overall trends in the material as
shown in (Figure S1). BAL-recovery values and BAL-recovery
Subway/Control (S/C) ratios were not significantly different
between the groups (p=0.2) and (p=0.6), respectively. No
correlation between recovery and lung function (FEV1) was found
(p=0.5). Concentrations adjusted for BAL-recovery (Table S2),
absolute concentrations (Table S3), and BAL-recovery information
(Table S4) are provided in the Supporting Information.
Immunocytochemistry
Approximately 60,000 BAL-cells/slide were cytocentrifuged
onto SuperFrostHPlus glass slides (Menzel-Gla ¨ser, Braunschweig,
Germany) at 450 rpm for 3 min for cell differential counts and
further analysis by immunocytochemistry. Fluorescent immuno-
cytochemistry was performed on the prepared cytospin slides with
monoclonal antibodies against 15-LOX-1 (dilution 1:1000, [23]),
peroxisome proliferator-activated receptor gamma (PPARc; dilu-
tion 1:100, Santa Cruz sc-7196) produced in rabbit, and COX-1
(dilution 1:200, Invitrogen 35–8100) and COX-2 (dilution 1:200,
Invitrogen 35–8200) produced in mouse. Cy5 labeled anti-rabbit
sera from donkey (dilution 1:1000, Amersham 711-175-152) and
Alexa488 labeled anti-mouse sera from goat (dilution 1:500–
1:1000, Molecular Probes A11001) were used as secondary
antibodies. Normal goat serum was purchased from Vector
Laboratories (Burlingame, CA, USA; S-1000 and S-4000) and
normal donkey serum from Sigma-Aldrich (D9663). Before
immunostaining, slides were fixed in 10% formalin and washed
in PBS before antigens were retrieved by boiling the slides in
citrate buffer for 30 min. Cell membranes were permeabilized by
methanol at 220uC for 10 min, washed in 0.4% PhotoFlo (Photax
K5010640) and air dried prior to rehydrating in PBS and blocking
Table 3. Response to subway air exposure normalized to








d 5-HETE 1.0 46 1.0 70 0.8
12-HETE 1.6 96 1.1 165 0.4
15-HETE 1.5 82 1.0 138 0.3
15-KETE 1.2 62 1.0 115 0.7
LTB4 1.1 50 1.2 75 0.7
6-trans-LTB4 0.9 48 1.0 58 0.6
TXB2 1.0 33 0.9 58 0.7
PGD2 1.5 100 1.0 113 0.3
PGE2 1.5 88 0.7 58 0.03
5(6)-EET 1.1 55 0.9 65 0.3
8(9)-EET 0.8 71 1.0 71 0.4
LA
e 9-HODE 2.7 98 0.8 47 0.01
9-KODE 2.3 91 1.0 60 0.02
13-HODE 1.6 59 0.8 86 0.01
13-KODE 2.1 92 0.9 63 0.02
EKODE 2.1 88 1.1 84 0.1
9,10,13-TriHOME 1.4 73 0.8 63 0.04
9,12,13-TriHOME 1.5 74 0.8 71 0.03
9,10-DiHOME 1.2 50 0.9 45 0.07
9(10)-EpOME 1.1 55 1.3 68 0.4
12,13-DiHOME 1.2 50 0.9 43 0.1
12(13)-EpOME 1.1 53 1.3 65 0.4
a-LA
f 9-HOTE 2.5 82 0.9 62 0.004
13-HOTE 1.5 44 0.9 75 0.01
EPA
g 12-HEPE 1.8 70 1.0 156 0.1
15-HEPE 1.6 80 0.9 133 0.1
DGLA
h 15-HETrE 1.8 125 1.0 151 0.2
DHA
i 17-HDoHE 1.4 69 1.0 125 0.3
ICC
j 15-LOX-1 1.1 77 1.6 89 0.4
COX-1 1.1 109 1.9 93 0.05
COX-2 1.1 31 1.2 79 0.4
PPARc 1.4 65 1.0 43 0.2
aOxylipin levels were normalized to the BAL-volume recoveries as described in
Table S2 and Table S4,
bCoefficients of variation (%),







jImmunocytoochemistry, RFU values normalized to DAPI intensities.
doi:10.1371/journal.pone.0023864.t003
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was blocked using antibody dilution buffer (ADB; 10% serum, 3%
BSA, 0.05% TritonX in PBS) for 30 min. Samples were incubated
in a dilution buffer of the primary antibody in a humidified
chamber at 4uC for 16 h. The slides were washed in 1) PBS
containing 0.4% PhotoFlo and 2) 0.01% TritonX, before being
incubated for 1 h with the secondary antibody. After repeating the
washing steps 1) and 2), the slides were counter-stained with 49,6-
diamidino-2-phenylindole, dihydrochloride (DAPI, Invitrogen
D1306) and mounted with ProLongH Gold antifade reagent
(Invitrogen P36930).
Visualization of the antigen-antibody complexes was performed
using fluorescent microscopy, and images were acquired using
Openlab (PerkinElmer, Waltham, MA, USA) and analyzed using
the ImageJ freeware [24]. Total fluorescence intensity was
measured for $100 cells in each slide from the same individuals
as the oxylipin measurements (asthmatics n=15, healthy individ-
uals n=16; insufficient patient material was available from 2
healthy individuals), background was subtracted and values were
normalized to the corresponding total fluorescent DAPI staining of
the corresponding cells in each slide. The choice of $100 cells for
sampling was based upon common protocols in cytology as
recently utilized by Gardner et al. [25]. The $100 quantified cells
were randomly selected from on average 3 representative
micrographs. Results are not reported for 3 healthy individuals
due to a failure to pass internal quality controls.
Statistical methods
Normalization for inter-individual variation was performed (i.e.,
Subway/Control [S/C]), improving study power from 0.60 to
0.73. No multiple hypothesis testing correction was performed
given that only 28 compounds were present above the LOQ,
which at an a=0.05 gives ,1.4 potential false positives. Relative
percent-composition was analyzed by grouping lipid metabolites
according to class. Distribution analysis was performed using
Shapiro-Wilks test (Analyse-it Software Ltd., Leeds, UK), and
univariate statistics were performed using either Mann-Whitney or
Student’s t-test depending on the normality and homoscedastic
nature of each variable (Prism, GraphPad Software, La Jolla,
USA). Multivariate analyses by orthogonal projections to latent
structures (OPLS) [26] were performed on S/C normalized data
using SIMCA-P+ 12 (Umetrics AB, Umea ˚, Sweden) following
mean centering and pareto scaling. For oxylipin data, only
compounds above the LOQ were included in the analysis. Cell
differential data were calculated as percent composition as
previously reported in [18,19] and protein data were based upon
the normalized intensity. Model performance was reported as
correlation coefficients (R





Sixty-four oxylipins representing 3 metabolic pathways (COX,
LOX and CYP) were screened using LC-MS/MS analysis.
Twenty-eight oxylipins were present above the method LOQ
and an additional 16 oxylipins present above the method limit of
detection (LOD) (Table S1). Oxylipin levels ranged over 1 pM to
8n M( .10
3; Table S2), with intra-group coefficients of variation
(CV) of 27–170% (Table 2).
Nine oxylipins were significantly altered between asthmatics and
healthy individuals in response to subway air exposure (Table 3,
Table S5): 9- and 13-hydroxyoctadecadienoic acid (HODE), 9-
and 13-oxooctadecadienoic acid (KODE), 9,10,13- and 9,12,13-
trihydroxyoctadecenoic acid (TriHOME), 9- and 13-hydroxyoc-
tadecatrienoic acid (HOTE), and PGE2 (p,0.05). The S/C ratio
of all 9 compounds evidenced an increase in the healthy
individuals following subway air exposure, whereas the asthmatics
exhibited little change or a decrease (Figure 1). All 9 oxylipins
Figure 1. Alterations in oxylipin levels in response to subway air exposure. Significant differences (p,0.05) in baseline normalized oxylipin
levels (Subway/Control, S/C) for healthy individuals (n=18) and asthmatics (n=15) following exposure to subway air. Values .1 indicate an increase
in concentration following subway air exposure, and values ,1 indicate a decrease.
doi:10.1371/journal.pone.0023864.g001
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with the exception of PGE2, which is a COX product of AA. In
addition, the majority of these oxylipins are synthesized via the 15-
LOX pathway as shown via their mapping to the KEGG pathway
for LA metabolism (Figure 2).
The absolute concentrations of several of these 9 oxylipins were
also significantly different (p,0.05, Table 2). Control levels of
PGE2 and 13-HOTE were significantly higher in asthmatics
compared to healthy individuals, in contrast to 9-KODE, which
was significantly lower (Figure S2). Following subway air exposure,
5 oxylipins from LA were significantly lower in asthmatics (9-
HODE, 9- and 13-KODE, 9,10,13- and 9,12,13-TriHOME). For
asthmatics, levels of 9-HODE and 9,12,13-TriHOME decreased
following exposure to subway air. Interestingly, only 9-HODE
evidenced significant shifts in both healthy individuals and
asthmatics following exposure to subway air, but the vector of
the change was opposite for the 2 groups, with an increase in
healthy and a decrease in asthmatics.
At baseline levels, the 15-LOX-produced 12- and 15-hydro-
xyeicosatetraenoic acid (12- and 15-HETE) as well as 15-
hydroxyeicosatrienoic acid (15-HETrE) were significantly higher
and EKODE was significantly lower in asthmatics compared to
healthy individuals (Figure S2). Following subway air exposure,
EKODE as well as 9,10- and 12,13-dihydroxyoctadecenoic acid
(DiHOME) were significantly lower in asthmatics compared to
healthy individuals. In healthy individuals, 8(9)-epoxyeicosatrie-
noic acid (EET) was significantly decreased after subway air
exposure.
To facilitate comparisons of global shifts in lipid metabolites,
oxylipin levels were summed upon the basis of the unsaturated
fatty acid substrate (e.g., AA). On a lipid class percent composition
basis, BAL-fluid was highly enriched in LA-derived metabolites,
representing ,70–80% of the overall oxylipin content as
compared to ,10–20% of AA metabolites. Other analyzed fatty
acid classes, including DHA and eicosapentaenoic acid (EPA),
were only represented by a few oxylipins in the analytical method.
All fatty acid classes examined evidenced significant differences
between healthy individuals and asthmatics at baseline levels
(p,0.05; Figure 3A–3B). In contrast, significant differences were
only observed in the linoleate and arachidonate oxylipin species
following exposure to subway air (Figure 3C–3D). No differences
were observed between the control and subway air exposure
profiles for either asthmatics or healthy individuals.
Of the individual oxylipins, the proportion of the LA epoxide
metabolites 12(13)-epoxyoctadecenoic acid (EpOME) and 9(10)-
EpOME, and their corresponding diols 12(13)- and 9(10)-
DiHOME, together represented ,40–50% of total detected
oxylipins in BAL-fluid (Figure S3). Other major BAL-fluid
components were 13-HODE and 15-HETE, representing ,10–
15% each of the overall profiles. Thus, the majority of the oxylipin
Figure 2. Alterations in oxylipin responses to subway air exposure mapped to the KEGG Linoleic Acid pathway (hsa00591).
Differences between groups are shown as ratios (asthmatics/healthy individuals) between self-normalized oxylipin levels (Subway/Control, S/C;
Table 3). Similar enzymatic conversions can occur via the a-linolenic acid pathway, but are not shown here (see KEGG pathway hsa00592). Data are
color-coded as described in the figure to display the ratio and were mapped to KEGG using the KegArray software as previously described [58].
doi:10.1371/journal.pone.0023864.g002
Effects of Subway Air on Asthmatics and Healthy
PLoS ONE | www.plosone.org 6 August 2011 | Volume 6 | Issue 8 | e23864content in BAL-fluid is represented by a small number of high
abundance metabolites.
Immunocytochemistry
Representative micrographs of the immunostaining of BAL-cells
against COX-1, COX-2, 15-LOX-1 and PPARc are shown in
Figure 4. Significant alterations were observed for COX-1
(Table 2), with levels following ambient air exposure higher in
healthy individuals relative to asthmatics (p=0.03, Figure 5B);
however no differences were observed following exposure to
subway air. COX-1 staining approached significance (p=0.054)
when evaluating the overall response to subway air exposure (i.e.,
S/C-normalized values) for asthmatics versus healthy individuals
(Figure 5A). No significant differences were observed for COX-2,
15-LOX-1 or PPARc (Table 3).
Multivariate modeling
Multivariate OPLS modeling investigating the overall trends in
the integrated oxylipin, immunocytochemistry, and clinical data
(including previously reported BAL-cell differential and T-cell
activation marker data [18,19]) resulted in a robust separation of




in projection (VIP) plots (Figure 6B–6C), the single most important
variable for driving the separation between groups was allergy
response.ThisvariableisconstructedfromthemaximalPhadiatopH
response observed in each individual, and thus reflects the degree of
atopy for the individual rather than the presence of atopy. Removing
this variable from the OPLS analysis weakened the model,
particularly in terms of predictive power (R
2Y(cum)=0.30,
Q
2(cum)=0.16). However, it also removed all significant orthog-
onal vectors, indicating that the intensity of the allergy response is
the main contribution factor to the orthogonal variance in the data
set. Removing the allergy variable did not change the overall trends
in the OPLS as indicated by the Shared and Unique Structures
(SUS) plot in Figure 6D. The 9 oxylipins identified as significantly
altered viaunivariatetesting werethemain contributingvariables to
the separationbetween healthy individuals and asthmatics following
allergy response (Figure 6B–6C), thus providing further evidence
that they are not false positives resulting from multiple hypothesis
testing. None of the variables derived from the immunostaining of
COX-1, COX-2, 15-LOX-1 or PPARc made major contributions.
Furthermore, no correlations between specific cell types and
oxylipins were observed. However, the CD4+ T-cells expressing
the activation marker CD25 were associated with asthmatics,
indicatingan inflammatoryresponse intheseindividuals inresponse
to subway air exposure. The prominence of the mast cell variable
should be interpreted with caution, as the majority of the
measurements for this cell type were close to the LOD, and below
the LOQ [18,19].
Discussion
The subway is a primary means of transportation in
metropolitan areas worldwide. In spite of recent reports of
significant toxicological effects of subway emission in vitro
[27,28], few studies have investigated the potential adverse effects
of exposure to this environment in vivo [7,18,19,29,30], particularly
in terms of sensitive subpopulations with respiratory disease. In
this study, we investigated the acute effects of exposure in the
Stockholm subway during rush hour traffic in mild intermittent
asthmatics and healthy individuals. To provide a quantitative
measure of subway air responses in the distal lung, the profiles of
pro- and anti-inflammatory oxylipins were studied in BAL-fluid. In
spite of being important in the complex interplay that regulates
inflammatory response and subsequent resolution, few of these
compounds have been investigated in the context of human lung
disease.
The trend for the 9 oxylipins found to be significantly altered
between asthmatics and healthy individuals was identical, with
exposure to subway air eliciting increases in the relative oxylipin
levels in healthy individuals, and decreases or no change in
asthmatics (Figure 1). Of these mediators, the COX product of
AA, PGE2 is the most well studied with both positive and negative
effects in asthma pathology (reviewed in [15]). The mediator has a
demonstrated bronchodilatory effect with inhibition of both early
and late phases, and mouse models indicate that COX-1 activity
has a predominately bronchoprotective effect. On the contrary,
COX-2 is mainly pro-inflammatory by causing infiltration of
inflammatory cells in the lung [31,32]. Accordingly, PGE2 can
exert diverse effects on the human lung that most likely are
regulated by different pathways. In this study, immunocytostaining
results for COX-1 showed significantly higher baseline expression
levels in healthy individuals relative to asthmatics (Figure 5B),
which lost significance following exposure to subway air. This
trend in COX-1 abundance in BAL-cells did not, however, follow
that of the observed PGE2 levels (Table 2). Furthermore, the
multivariate modeling did not reveal any correlations between
Figure 3. BAL-fluid oxylipin composition among patient
groups. Following exposure to control air, healthy individuals (A)
and asthmatics (B) evidenced significant differences in oxylipin levels on
a fatty acid class-specific basis for linoleates (LA; p=0.004), arachido-
nates (AA; p=0.008), docosahexaenoates (DHA; p=0.045), dihomo-c-
linolenates (DGLA; p=0.007), a-linolenates (a-LA; p=0.035) and
eicosapentaenoates (EPA; p=0.045). Following exposure to subway
air, only LA (p=0.022) and AA (p=0.013) were significantly different
between healthy individuals (C) and asthmatics (D). No significant
changes were observed in healthy individuals or asthmatics following
exposure to subway air, relative to exposure to control air; (A) vs (C) and
(B) vs (D), respectively. The unlabeled fatty acids (DGLA, a-LA, EPA and
DHA) are all present at ,5% and are presumably more representative of
a lack of coverage in the analytical method rather than potential
biological differences in relative abundance.
doi:10.1371/journal.pone.0023864.g003
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COX-1 levels in BAL-cells may not be directly of relevance to the
observed PGE2 alterations.
The other 8 oxylipins with significantly different responses
following subway air exposure are metabolites originating from LA
or a-LA. These mediators are all from the 15-LOX pathway
(Figure 2) and clustered together in the multivariate modeling,
further suggesting that they may be co-regulated (Figure 6). The
observation that these oxylipins were the main driving variables
for the OPLS model, regardless of whether the allergy response
was included in the model (Figure 6D), further stresses their
importance in differentiating the biological response between
asthmatics and healthy subpopulations. The human variant of the
15-LOX enzyme in monocytes and alveolar macrophages can be
induced by interleukins associated with asthma, including IL-4 and
IL-13 (reviewed in [33]). Accordingly, the prevalence of 15-LOX-
1 in BAL-cells was examined via immunocytochemistry. However,
no alterations were observed in 15-LOX-1 levels in BAL-cells
between healthy individuals and asthmatics following exposure to
either ambient or subway air (Figure 4 and Figure 5). The lack of
alterations in 15-LOX-1 expression is also in concordance with
previous studies in asthmatics [34]. The observed increase of 15-
LOX metabolites in healthy individuals may consequently be
derived from other cell types in the lung. Several cell types in the
respiratory tract possess the potential to express 15-LOX-1,
including bronchial epithelial cells, alveolar macrophages, eosin-
ophils, and mast cells, with epithelial cells evidencing the greatest
levels of 15-LOX-1 [35,36]. It is therefore likely that the observed
shifts in oxylipin levels are due to 15-LOX activity in epithelial
cells.
Among the significantly altered 15-LOX products, 13-HODE is
the most well studied LA derivative and of demonstrated
importance in airway disease [33,37]. 13-HODE has been shown
to alter the activity of the anti-inflammatory receptor PPARc in a
concentration dependent manner [33,38,39]. PPARc has been
proposed to be closely involved in regulating the inflammatory
states underlying many airway diseases [40,41] and PPARc
agonists have been suggested as alternative anti-inflammatory
therapeutics in asthma [42]. Three other linoleate metabolites with
demonstrated binding affinity to PPARc, 9-HODE, 9-KODE and
13-KODE [38,43,44], were also significantly altered between
asthmatic and healthy individuals, and main driving variables in
the multivariate model (Figure 6). However, no alterations in
PPARc protein expression were found in BAL-cells (Figure 4 and
Figure 5). The other LA-derived oxylipins, the TriHOMEs, have
not been extensively studied in the literature and little is known
about their biological function. Given the observed shifts in their
levels following exposure to subway air, as well as in other studies
Figure 4. Fluorescent immunocytochemistry was performed on cytospun BAL-cells using monoclonal antibodies against COX-1,
COX-2, 15-LOX-1 and PPARc coupled with secondary antibodies labeled with fluorescent dyes Alexa488 (green) and Cy5 (red).
Nuclear counter-staining was performed using DAPI (blue). Representative micrographs from a healthy and an asthmatic individual are shown for
both the control air (A) and subway air (B) exposures. Semi-quantitative evaluation of staining intensities was performed using ImageJ software [24].
doi:10.1371/journal.pone.0023864.g004
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further investigation.
Several studies have suggested that high 15-LOX activity and
the levels of the AA 15-LOX product 15-HETE are mainly
indicative of pro-inflammatory responses in asthma [34,36,45]. In
this study, the concentrations of 15-HETE were significantly
greater in asthmatic baseline levels (Table 2 and Figure S2), but
not following subway air exposure. This difference could be
suggestive of healthy individuals having lower lung inflammatory
activity at baseline levels, which could also explain why subway air
appears to elicit a more active response in the healthy individuals.
To date, little is known of the global oxylipin metabolic
composition of BAL-fluid in human subjects. At baseline levels,
profiles of all fatty acid classes in BAL-fluid were significantly
different when analyzed on a percent composition basis (Figure 3).
Particularly the ratios of LA:AA metabolites between asthmatics
and healthy individuals were different, with healthy individuals
evidencing a LA:AA ratio of 6.3 relative to 3.4 in asthmatics
(Figure 3). The biological significance of these compositional
differences is unclear, but exposure to subway air had little effect
upon the overall metabolic LA:AA ratios (7.6 and 3.7 for healthy
individuals and asthmatics, respectively). The higher prevalence of
linoleates in healthy individuals compared to asthmatics is
contrary to the mounting hypothesis of high LA consumption as
a risk factor for developing allergic diseases, including asthma [46].
This theory is however based on the abundance of the LA
precursor, which can be readily converted to AA in vivo via the D6-
desaturase prior to further metabolism to the AA-derived
oxylipins. In addition, in a cystic fibrosis model, both in vitro and
in vivo studies reported that LA supplementation increased the level
of AA-derived pro-inflammatory oxylipins [47]. Accordingly, these
observations suggest that any manifested biological effects are most
likely due to small changes in specific compounds rather than
overall lipid classes.
The results in Figure 1 and Figure 3 show a clear predominance
of LA-derived relative to AA-derived oxylipins, both in terms of
overall abundance as well as shifts following subway air exposure.
These observations can be explained in terms of enzyme substrate
specificity and relative abundance of the individual fatty acid
precursors. In contrast to COX-1 and COX-2, which have
preferred substrate specificity for AA [10,48,49], 15-LOX uses
both LA and AA as substrate [50]. However, LA is the preferred
substrate for 15-LOX in vitro [51] as well as in human
tracheobronchial epithelial cells [52]. In lung tissue from healthy
individuals, AA and LA amounts have been reported in 1:1 ratios
[53]; however in human bronchial epithelial cells (the likely source
of the oxylipins quantified in this study) the levels of AA are ,2/3
of LA [54]. Accordingly, for data interpretation it is important to
consider both the relative fatty acid levels in different cellular
environments as well as the enzyme substrate specificity.
Subway air has a unique composition relative to other sources of
urban air pollutants both in terms of chemical composition and
particulate size [55]. Several in vitro studies have indicated that PM
from subway air is more genotoxic than PM from the street level
[27,28]. In contrast to PM from road emission consisting primarily
of combustion-related PM, subway PM is formed from wear and
tear of rails and train brakes. This results in a concomitant high
iron content, which can act as catalyst and cause oxidative stress
through redox cycling [27]. In comparison to a previous road
tunnel air exposure study performed with the same study design
and sampling equipment, the current study represented compa-
rable levels of PM10 (242640 mg/m
3) and PM2.5 (77610 mg/m
3)
[18,20], which is in rough agreement with previously published
work [6]. In spite of the similarities in PM exposure levels, these
environments elicited distinctly different inflammatory responses
in healthy individuals. In particular, the significant increases in the
number of inflammatory cells and cytokines observed following
road tunnel air exposure were not observed following subway air
exposure [18,19]. The oxylipin results do however tell a different
story, indicative of a clear response following subway air exposure
in spite of the absence of classical inflammatory indicators.
Arguably, the observed differences in responses between asthmat-
ics and healthy individuals may be the result of airway constriction
in the asthmatics, which could alter dose or site of impact of the
exposure. However, close monitoring of the lung function
throughout the study, including peak expiratory flow (PEF),
spirometry, and exhaled NO [18,19], showed that subway air
exposure did not elicit any airway constriction. As such, the lack of
alterations in oxylipin levels in asthmatics is not likely to be an
effect of altered airflow patterns. In contrast, the previously
reported increase in CD4+CD25+ cells in asthmatics, but not in
healthy subjects, indicates that the asthmatics have an ongoing
inflammatory response that is absent in healthy individuals.
Conversely, an increase in regulatory T-cells (Treg;
FoxP3+CD4+CD25+) in healthy, but not in asthmatic subjects
following subway air exposure is indicative of an ongoing anti-
Figure 5. Semi-quantitative analysis of immunostained cytos-
pun BAL-cells. (A) Baseline normalized expression levels (Subway/
Control, S/C) for immunostaining of BAL-cells revealed an intensified
response in asthmatics compared to healthy individuals for COX-1
(p=0.054). Values .1 indicate an increase in concentration following
subway air exposure and values ,1 indicate a decrease. (B) Analysis of
the subway air and control exposures as separate groups gave
significantly lower COX-1 levels in asthmatics compared to healthy
individuals at baseline levels (p=0.03).
doi:10.1371/journal.pone.0023864.g005
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asthmatics. As such, the biological activity of the observed
oxylipins may have an attenuating effect on inflammation. It is
noteworthy that a single exposure well below levels classified as
harmless to workers in the New York [7,56] and London [8]
subway systems, elicits such a divergent response in healthy and
asthmatic populations.
The data presented here are potentially suggestive of an overall
defensive response in healthy individuals following exposure to
subway air that is not observed in asthmatics. This observation
could either be an indication of a decreased initial acute response
following exposure to subway PM similar to that observed
following exposure to diesel exhaust [57], or an indication of a
hampered ability to attenuate the initial acute inflammation
among asthmatic subjects. The relative importance of the
previously reported increase of activated T-cells in the asthmatic
group following subway exposure in the multivariate models
(Figure 6D), in conjunction with previously reported increases in
Treg cells in healthy individuals, but not asthmatics, following
subway air exposure are indicative of the latter [18,19].
Furthermore, the relative oxylipin profiles are suggestive of
involvement of the 15-LOX pathway in these processes, which
may be relevant to disease etiology and the overall pathology of
asthma.
Conclusion
In this study distinct fluctuations in oxylipin levels were
observed, suggesting that subway air can trigger responses in the
human lung in a pathology-dependent manner. In particular,
these data show that asthmatics possess different oxylipin profiles
compared to healthy individuals, both at baseline levels and in
response to exposure to Stockholm subway air. This study is the
first to report metabolic profiling of oxylipin levels in human BAL-
fluid, with results suggesting that this matrix may provide a
Figure 6. OPLS analysis integrating oxylipin, immunocytochemistry and clinical variables, with asthma diagnosis as the sole
response variable. The scores plot (A) shows a robust separation of asthmatics (red dots) and healthy individuals (black dots) into 2 distinct groups.
The loading (B) and VIP plots (C) indicate that in addition to the allergy response variable, the 12/15-LOX metabolites are driving the separation of the
2 groups. Error bars indicate 95% confidence interval. The SUS plot (D) correlates OPLS models that include (x-axis) and exclude (y-axis) the allergy
response variable, revealing a high level of correlation between the models, suggesting that removal of the allergy response variable does not affect
the model contribution of the remaining variables. Oxylipin abbreviations are as described in the text and Table S1, VC=vital capacity, FVC=forced
vital capacity, and FEV1=force expiratory volume in 1 sec.
doi:10.1371/journal.pone.0023864.g006
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airway that are not detectable with classical inflammatory markers.
The distinct responses in oxylipin profiles between healthy
individuals and asthmatics suggests that these components are
important in asthma pathology, and their use for monitoring
purposes as well as treatment should be further examined.
Supporting Information
Figure S1 Coefficients of variance (CVs) for all oxylipins
before and after BAL-fluid recovery volume normaliza-
tion (norm). These data support the decision to normalize the
oxylipin data with the BAL-fluid recovery volumes due to a
decrease in the observed CVs. Abbreviations: AS: Asthmatics
following subway air exposure; AC: Asthmatics following control
air exposure; HS: Healthy individuals following subway air
exposure; HC: Healthy individuals following control air exposure.
(TIF)
Figure S2 Oxylipin baseline concentrations (pM) of
those metabolites indicating significantly different lev-
els between healthy individuals and asthmatics.
(TIF)
Figure S3 Oxylipin composition in BAL-fluid of the 4
different exposure groups. Oxylipin naming is as provided in
Table S1, with data taken from Table 2.
(TIF)
Table S1 Detected and quantified oxylipins as well as
oxylipin nomenclature.
(XLS)
Table S2 Individual oxylipin concentrations normalized
for BAL-fluid recoveries (pM).
(XLS)
Table S3 Absolute oxylipin concentrations (pM).
(XLS)
Table S4 BAL-fluid recovery volumes for bronchosco-
pies.
(XLS)
Table S5 Individual values for Subway/Control (S/C)
normalization of oxylipin levels.
(XLS)
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